Skip to content
Sunday, August 7, 2022
Latest:
  • The path forward: a more inclusive healthcare system
  • Raising awareness of spina bifida
  • Fertility Series: Advanced maternal age
  • Video of the Month: A beating developing mouse heart
  • Summer camp at Home

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

CDKN2A gene

From The Labs 

Exploring the risk of ALL in children with Down syndrome

September 24, 2019September 24, 2019Acute Lymphoblastic Leukemia, ALL, CDKN2A gene, Childhood leukemia, Down syndrome, IKZF1 gene, Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL

Read more

From the Labs Video of the Month

From The Labs Image of the Month From the Labs: A beating developing mouse heart.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951